• Pravastatin Sodium: Mechanistic Insights and Translational U

  2026-06-03

  Explore the mechanistic depth of Pravastatin sodium as a selective HMG-CoA reductase inhibitor, its role in cholesterol biosynthesis inhibition, and advanced assay guidance for translational research—delivering a unique, evidence-based perspective beyond standard protocols.

• ISRIB (trans-isomer): Transforming ER Stress and Fibrosis Re

  2026-06-03

  Discover how ISRIB (trans-isomer) uniquely advances ER stress and liver fibrosis research as a potent PERK inhibitor. Explore mechanistic insights, new assay strategies, and the latest breakthroughs for translational scientists.

• Epigenetic Mcl-1 Targeting and BCL-XL Inhibition in Glioblas

  2026-06-02

  This study reveals that simultaneous epigenetic suppression of Mcl-1 and pharmacological inhibition of BCL-XL/BCL-2 produces synthetic lethality in glioblastoma models. The work provides a mechanistic rationale for exploiting apoptosis pathway vulnerabilities to overcome therapeutic resistance in aggressive brain tumors.

• Valemetostat (DS-3201): Redefining Epigenetic Cancer Therapy

  2026-06-02

  Discover how Valemetostat (DS-3201), a dual EZH1/EZH2 inhibitor, is reshaping epigenetic cancer therapy by integrating cutting-edge immunogenic reprogramming insights with advanced protocol strategies for lymphoma and beyond.

• Thiothixene: Typical Antipsychotic Agent in Effercytosis Res

  2026-06-01

  Thiothixene bridges psychiatric and immunological research, enabling robust workflows for both schizophrenia models and in vitro macrophage efferocytosis enhancement. This guide details protocol refinements, troubleshooting, and translational insights to maximize data fidelity with APExBIO’s trusted product.

• AP20187: Precision Chemical Inducer of Dimerization in Gene

  2026-06-01

  AP20187 enables precise, reversible control over fusion protein dimerization and gene expression, setting new standards for conditional gene therapy activators. Its high solubility, validated in vivo efficacy, and robust performance in 14-3-3 signaling research make it a cornerstone for innovative experimental design.

• Structural Insights into CD38 CAR Affinity Tuning and Select

  2026-05-31

  This study provides a structural and functional dissection of two CD38-targeting CAR binders, detailing how specific epitope engagement and rational affinity engineering can enhance therapeutic selectivity and minimize CAR-T fratricide. The findings offer a framework for optimizing CD38 CAR design by balancing antigen binding affinity, enzymatic inhibition, and cellular specificity.

• 2-D08 (2’,3’,4’-trihydroxyflavone): Mechanistic Insight for

  2026-05-30

  Discover how 2-D08 (2’,3’,4’-trihydroxyflavone) enables highly selective SUMOylation inhibition, with new mechanistic depth for cancer research and mitochondrial biology. This article delivers unique protocol guidance and practical insights not covered in prior reviews.

• Refining In Vitro Drug Response Assessment in Cancer Researc

  2026-05-29

  Schwartz's dissertation introduces a nuanced framework for evaluating anti-cancer drug responses in vitro by distinguishing between proliferative arrest and cell death. This approach reveals how different antineoplastic agents, such as Dacarbazine, can variably influence cancer cell proliferation and survival, providing new guidance for preclinical assay design and interpretation.

• SAR405: Vps34 Inhibitor Workflows for Autophagy Research

  2026-05-29

  SAR405 enables precise, ATP-competitive Vps34 inhibition for dissecting autophagy and vesicle trafficking in cellular models. This guide translates bench-proven protocols and troubleshooting insights into actionable steps, spotlighting SAR405’s unique selectivity, its role in advanced disease modeling, and how it complements evolving AMPK-ULK1 mechanistic frameworks.

• Ca2+-Dependent Autophagy and Lysosomal Alkalinization in GBM

  2026-05-28

  This study reveals that NNC-55–0396 induces cytotoxicity in glioblastoma cells by activating Ca2+-dependent autophagy and disrupting lysosomal acidification. The findings clarify how modulation of calcium signaling and autophagic flux can be leveraged to target resistant cancer cell populations, informing future research on Ca2+-mediated therapeutic strategies.

• Amitriptyline HCl: Technical Guide for Neuropharmacology Wor

  2026-05-28

  Amitriptyline HCl (SKU B2231) is a validated research compound for precise neurotransmitter receptor modulation in neuropharmacology, mood disorder, and neurodegenerative disease models. This article guides researchers in maximizing reproducibility, stability, and workflow integrity using this tricyclic compound. It should not be used in protocols requiring long-term solution stability or outside the documented receptor targets.

• Temporal Transcriptomics Reveal Host Targets for Anti-EBOV T

  2026-05-27

  This study integrates time-resolved transcriptomics and systems biology to uncover early host gene modules exploited by Ebola virus (EBOV) and identifies actionable targets for host-directed antiviral intervention. The approach demonstrates how dynamic network analysis and pharmacological screening, including validation of BAY-43-9006 (Sorafenib), can accelerate discovery of broad-spectrum antiviral strategies.

• Acetylcholine Chloride: Mechanisms and Evidence in Cholinerg

  2026-05-27

  Acetylcholine Chloride is a key acetylcholine neurotransmitter analog enabling precise study of neuromuscular and autonomic signaling. Its well-characterized solubility, mechanism, and purity support robust benchmarks in cholinergic pathway research. New clinical and translational findings underscore its central role in gut-brain signaling studies.

• Oligo (dT) 25 Beads: Optimizing Eukaryotic mRNA Isolation Wo

  2026-05-26

  Oligo (dT) 25 Beads revolutionize eukaryotic mRNA isolation by enabling rapid, high-yield purification directly from complex samples. Discover how these superparamagnetic beads streamline downstream assays, drive reproducibility, and empower advanced transcriptomics in translational research.

408 records 13/28 page Previous Next First page 上5页 1112131415 下5页 Last page